Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

How the Evolution of Sintered Porous Plastics is Furthering our Understanding of Cancer and Other Diseases

publication date: Oct 17, 2014
 | 
author/source: Porvair Filtration Group

The fight against cancer could be aided by new technical advances in filtration and separation technology.

porviar filtrationPorvair Filtration Group believes that the evolution of its range of sintered porous plastics can help molecular biologists and clinicians better understand the mechanisms underlying cancer and other diseases.

Scientists at the Wrexham division have developed BioVyon™ porous plastic materials which can now be used in a wide variety of medical and pharmaceutical applications to offer better healthcare, improve medical knowledge and help with the diagnosis and treatment of diseases.

The utility of BioVyon™, coupled to Protein A or G or other highly selective biochemical reagents such as antibodies, opens up a whole range of new assay tools to help molecular biologists and clinicians understand diseases - and more of these assays kits are in Porvair’s product development pipeline.

BioVyon™ is a highly versatile plastic which can be employed in a wide range of functions across the entire medical sector. The requirements of materials for these market sectors are usually far more stringent than that for industrial applications.

They need to be contamination-free with very low levels of leachables and with full traceability. Regulatory approval is also an essential prerequisite for many products in these sectors.

Sintered porous plastics - whereby porous materials are produced by fusing together plastic particles using controlled application of heat - have been used for many years for a myriad of industrial processes.

These sintered materials can be made from most thermoplastic polymers but are primarily made from polyethylene or polypropylene and are typically produced with a pore size range from five to 100 micron and with porosities between 35 to 50 per cent (open volume).

Porvair’s sintered porous products are available in a wide variety of shapes and sizes, as small as 2mm or as large as 2m in diameter. They can be moulded into complex three dimensional shapes, or cut from roll or flat sheet. The defined pore size distribution combined with a material exhibiting excellent robustness and chemical resistance are essential properties for these applications.

The Vyon® range of porous materials also offer excellent chemical compatibility, exceptional strength and are resistant to most acids, bases, many organic chemicals and temperatures up to 110ºC (230ºF).

Typical industrial applications include water and air filtration, sound attenuation, fragrance emanation, vacuum table beds, powder fluidisation and battery venting.

Porvair’s Market Manager Roy Rigby said: “Since 2007 the BioVyon™ range of materials has grown. It continues to expand and is being used in such applications as drug filtration and purification, catheter vents, bone cement mixing in the operating theatre and nasal spray filters.

Now, with BioVyon™ being coupled to biomolecules such as Protein A or G, and antibodies too, a whole range of possibilities have opened up.”

Porvair’s Head of New Product Development Dr David Cowieson said: “New assay tools such as the Chromatrap® kit range are helping molecular biologists and clinicians to gain a better understanding of the causes of cancer and other common diseases.

“More tools are on the way and many of them are designed to facilitate automation for high throughput applications which could revolutionise the pace of this work.

“Our scientists have been genuinely excited by the opportunities that they have helped to realise in the laboratory that can then be implemented for wide healthcare benefits, the refinement of medical knowledge, and in the diagnosis and treatment of disease.”


more about the Porvair Filtration Group


more news from the Porvair Filtration Group


 


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events